Cargando…
Randomized, Crossover and Single-Dose Bioquivalence Study of Two Oral Desogestrel Formulations (Film-Coated Tablets of 75 μg) in Healthy Female Volunteers
Despite the increase in the substitution of branded medicinal product with generic drugs, this is a controversial issue for some pharmacological groups (such as contraceptives). The aim of the present clinical trial was to assess the bioequivalence and tolerability of two oral formulations of desoge...
Autores principales: | Pena, María Ángeles, Sanz, Emilio, Francisco, Silvia, Alonso, Ainhara, Abajo, Zurine, Felipe, Izaskun, Pascual, Jaume, Tost, Digna, Bailac, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Österreichische Apotheker-Verlagsgesellschaft
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383212/ https://www.ncbi.nlm.nih.gov/pubmed/22896827 http://dx.doi.org/10.3797/scipharm.1111-18 |
Ejemplares similares
-
Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations
por: Algorta, Jaime, et al.
Publicado: (2008) -
Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days
por: Merki-Feld, Gabriele S, et al.
Publicado: (2015) -
Desogestrel: Arterial thrombosis: case report
Publicado: (2021) -
The Uncharted Link Between Desogestrel and Hypercalcemia
por: Utpat, Nishka, et al.
Publicado: (2023) -
Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen)
por: Bitzer, Johannes, et al.
Publicado: (2015)